Dudediligence.

Axogen, Inc

AXGNNASDAQ · Electromedical & Electrotherapeutic Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$48.6MSep ’24$49.4MDec ’24$48.6MMar ’25$56.7MJun ’25$60.1MSep ’25$59.9MDec ’25$61.5MMar ’26$69.7MJun ’26
Net income, by quarter
−$1.9MSep ’24$450,000Dec ’24−$3.8MMar ’25$579,000Jun ’25$708,000Sep ’25−$13.2MDec ’25−$19.6MMar ’26−$1.5MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$127.4M$138.6M$159.0M$187.3M$225.2M
Gross profit$104.4M$108.8M$121.9M$142.0M$167.4M
Operating income−$25.4M−$29.7M−$21.5M−$3.3M−$7.8M
Net income−$27.0M−$28.9M−$21.7M−$10.0M−$15.7M
Operating cash flow−$13.4M−$16.1M−$5.7M$4.5M$812,000
Free cash flow−$41.2M−$36.1M−$19.6M$1.4M−$2.9M
Cash$32.8M$15.3M$31.0M$27.6M$35.5M
Debt$44.8M$45.7M$46.6M$47.5M$48.4M
Shares outstanding41.7M42.4M43.1M44.1M47.2M